Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Long Term Cardiotoxicity Surveillance in Hsct Publisher



Nodehi SRS1 ; Alizadehasl A2 ; Roudini K3 ; Ranjbar H4 ; Parsa NA5
Authors

Source: Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Published:2024


Abstract

Hematopoietic stem cell transplantation*Pretransplant*Cardiovascular evaluation*Cardiac function*Heart failure*Echocardiogram*Cardio-toxicit © Springer Nature Switzerland AG 2024. All rights reserved.
Related Docs
View other Related Docs
1. Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review, International Journal of Hematology-Oncology and Stem Cell Research (2025)
2. Pre-Hsct Cardiovascular Evaluation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
3. Burden of Cardiovascular Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
Experts (# of related papers)
View all Related Experts
Amir Hossein Emami (4)
Mohammad Vaezi (3)
Other Related Docs
4. Risk Factors and Mechanisms of Cardiotoxicity in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
5. Cardiovascular Diseases in Patients After Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis, Current Research in Translational Medicine (2023)
6. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
7. Rehabilitation in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
8. Cardiotoxicity of Commonly Used Drugs in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
9. Compare Cpm-Rmi Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived Cd133+ Cells and Mncs During Cabg in Patients With Recent Mi: A Phase Ii/Iii, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial, Cell Journal (2018)
10. Pulmonary Hypertension in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
11. Pericardial Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
12. Animal- and Human-Based Evidence for the Protective Effects of Stem Cell Therapy Against Cardiovascular Disorders, Journal of Cellular Physiology (2019)
13. Recent Advances in Cardiac Regeneration: Stem Cell, Biomaterial and Growth Factors, Biomedicine and Pharmacotherapy (2017)
14. Regenerative Medicine in Organ and Tissue Transplantation: Shortly and Practically Achievable?, International Journal of Organ Transplantation Medicine (2015)
15. Improvement of Heart Failure by Human Amniotic Mesenchymal Stromal Cell Transplantation in Rats, Journal of Tehran University Heart Center (2016)
16. Optimizing Peripheral Blood Stem Cells Transplantation Outcome Through Amend Relapse and Graft Failure: A Review of Current Literature, Experimental Hematology and Oncology (2017)
17. Dyskeratosis Congenita Future: Hematopoietic Stem Cell Transplantation or Gene Therapy?, Gene Reports (2025)
18. Stem Cells and Heart Tissue Regeneration, Nanomedicine for Ischemic Cardiomyopathy: Progress# Opportunities# and Challenges (2020)
19. Therapeutic Angiogenesis Promotes Efficacy of Human Umbilical Cord Matrix Stem Cell Transplantation in Cardiac Repair, Iranian Journal of Basic Medical Sciences (2015)